RxDoctor Payments Data

Peter Farano, MD

Anatomic Pathology & Clinical Pathology · Philadelphia, PANPI 1194743989

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,546 of the $2,192 with a category attached, or 70.5%. Beckman Coulter, Inc. accounts for 72.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $1,603 and has fallen 97.9% since, to $33 in 2025. Among anatomic pathology & clinical pathology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,192in general payments, 2019–2025

Across 25 payments — averaging $87.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Beckman Coulter, Inc.$2K
  • Siemens Medical Solutions USA, Inc.$235
  • Boehringer Ingelheim$104
  • Bristol Myers Squibb$66
  • Tesaro, Inc.$55
  • Eisai Inc.$42
  • plus $106 from 6 others

What the payments were for

  • Travel & lodging$1,54671%
  • Food & beverage$64629%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,192 in reported general payments places this provider in the 90th percentile of 357 anatomic pathology & clinical pathology providers in Pennsylvania.

See all anatomic pathology & clinical pathology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$3,493
Medicare patients
92
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →